ArticleAmerican journal of preventive cardiology2025
Machine learning applied to wearable fitness tracker data and the risk of hospitalizations and cardiovascular events.
Article in American journal of preventive cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Artificial Intelligence in Cardiovascular Medicine: Focus on Hypertension.Hypertension (Dallas, Tex. : 1979) · 2026Pooled it
- Wearable devices and cardiovascular health: revolutionizing remote monitoring and disease prevention.European heart journal · 2026Review
- AJPC 2025 in review: A year of growth & clearer mandate for actionable prevention.American journal of preventive cardiology · 2026Article
- Implementation of Machine Learning in Heart Failure Trials.Current heart failure reports · 2026Review
- Early Identification of Hospital Visit Risk in Heart Failure Using Wearable-Derived Data.medRxiv : the preprint server for health sciences · 2026Article
- Effect of nighttime bedroom temperature on heart rate variability in older adults: an observational study.BMC medicine · 2025Observational
- AI-based neoadjuvant immunotherapy response prediction across pan-cancer: a comprehensive review.Cancer cell international · 2025Review
- Coronary heart disease risk prediction based on GAIN imputation and interpretable machine learning.Frontiers in genetics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWearable fitness trackers generate extensive physiological and activity data, offering potential to monitor health and predict outcomes. Machine learning (ML) techniques applied to these data may enable early identification of adverse health conditions, such as hospitalizations and development of cardiovascular diseases (CVD). This study aimed to evaluate ML models' ability to forecast the incidence of (1) hospitalizations from any cause and (2) of new diagnosis of CVD, including a composite of heart failure (HF), coronary artery disease or myocardial infarction (CAD-MI), cardiomyopathy (CMP), and atrial fibrillation (AF). METHOD AND
resultsData from 14,157 participants in the All of Us study that included both Fitbit and electronic health record (EHR) information were censored on the date preceding events and analyzed using various ML classifiers for extracted feature data. Performance metrics included accuracy, area under the receiver operating characteristic (AUROC) curve, and F1 scores. Our overall study population was young (median age 54 years), with good representation of women (67%). For hospitalizations, a Random Forest classifier achieved the best performance (AUROC=0.95, accuracy=0.99, F1 score=0.92). For the CVD events, the best prediction model was gradient boosting (AUROC=0.80, accuracy=0.71, F1 score=0.15).
conclusionML models applied to Fitbit data demonstrate promise in predicting clinical outcomes with strong performance for predicting all-cause hospitalizations and modest performance for predicting incident CVD. Wearable technology could play a role in risk assessment and patient management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.